Geographically, the Liver cancer therapeutics Market is divided into North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. Due to increased government investment for R&D operations, North America is anticipated to maintain its leadership position over the projection period. The American Liver Foundation has funded more than US$ 26 million in research since 1979. Its mission is to promote education, support, and research for the prevention, treatment, and cure of liver disease. In addition, compared to economies in the United States, Sub-Saharan Africa and Southeast Asia have higher rates of liver cancer. Around 83 percent of the anticipated 782,000 new cases of cancer reported globally in 2012, with 50 percent occurring in China alone, according to GLOBOCAN. The Liver cancer therapeutics Market is expanding as a result of the increased risk of cancer development and death in Sub-Saharan African nations due to late-stage detection and inadequate treatment.
Read More:
https://knackersblogger.blogspot.com/2022/06/liver-cancer-therapeutics-market-global.html
